23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › INARI MEDICAL INC. › 2023-2024

INARI MEDICAL INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and INARI MEDICAL INC.’s Form 8-K, filed April 25, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 6Ballot items
  • 310Asset managers, any item
  • 2,562Fund votes
  • April 24, 2024Meeting date

Results at a glance

Meeting of April 24, 2024: 6 items on INARI MEDICAL INC.’s Form 8-K, filed April 25, 2024: 4 elected · 2 approved.

Dissent

Significant dissent: 4 directors (27.6%, 26.6%, 20.6%, 20.3% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024

Explore INARI MEDICAL INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by INARI MEDICAL INC.

These tallies are INARI MEDICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

INARI MEDICAL INC. — official shareholder meeting results, meeting held April 24, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rebecca Chambers 37,413,521---- 9,684,1986,045,772 79%Elected—
Elect Director: William Hoffman 33,808,366---- 12,904,0666,431,059 72%Elected—
Elect Director: Andrew Hykes 37,514,003---- 9,583,7166,045,772 80%Elected—
Elect Director: Donald Milder 34,564,964---- 12,532,7556,045,772 73%Elected—
2. The selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024 53,055,76838,76148,962 --0 99.9%Approved—
3. The compensation of the Company's named executive officers as disclosed in our proxy statement 44,404,4872,164,720546,058 --6,028,226 95%Approved—

Source: INARI MEDICAL INC., Form 8-K, filed with the SEC on April 25, 2024 — read the filing on EDGAR.

How asset managers voted at the INARI MEDICAL INC. 2023-2024 meeting

310 asset managers disclosed a vote on at least one INARI MEDICAL INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Andrew Hykes

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD
FOR: 37,514,003WITHHELD: 9,583,716
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Andrew Hykes

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Andrew Hykes”): 37,514,003 for, 9,583,716 withheld, per its Form 8-K filed April 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the following Class I director nominees was elected to serve on the Company's board of directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders, by the following vote:”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 97 asset managers below reported 19,690,203 for, 69 against, 3,697,832 withheld.

FORWITHHOLD
FOR: 19,690,203AGAINST: 69WITHHOLD: 3,697,832
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 0562,715Withhold
American Century00 0551,255Withhold
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 0408,888Withhold
Principal170,3830 0212,697Mixed
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS00 0321,135Withhold
State Street309,4990 0251For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price272,1410 00For
Jackson National100,4250 0148,879Mixed
New York Life159,1710 089,332Mixed

Showing the 25 largest of 97 asset managers. All 97 are in the interactive database (link above).

Elect Director: Donald Milder

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD
FOR: 34,564,964WITHHELD: 12,532,755
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Donald Milder

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Donald Milder”): 34,564,964 for, 12,532,755 withheld, per its Form 8-K filed April 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the following Class I director nominees was elected to serve on the Company's board of directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders, by the following vote:”
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 97 asset managers below reported 17,095,988 for, 69 against, 6,292,047 withheld.

FORWITHHOLD
FOR: 17,095,988AGAINST: 69WITHHOLD: 6,292,047
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,176,7760 030,970For
AllianceBernstein00 0749,586Withhold
JPMorgan670,3920 00For
Voya00 0591,407Withhold
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 0562,715Withhold
American Century00 0551,255Withhold
AB DISCOVERY GROWTH FUND, INC.00 0479,248Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 0408,888Withhold
Principal5760 0382,504Withhold
Northwestern Mutual381,4050 00For
Equitable103,0200 0278,228Mixed
MFS00 0321,135Withhold
State Street309,4990 0251For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 0272,141Withhold
Jackson National100,4250 0148,879Mixed
New York Life159,1710 089,332Mixed

Showing the 25 largest of 97 asset managers. All 97 are in the interactive database (link above).

Elect Director: Rebecca Chambers

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 37,413,521WITHHELD: 9,684,198
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca Chambers

INARI MEDICAL INC.’s own tally for this item (“Elect Director: Rebecca Chambers”): 37,413,521 for, 9,684,198 withheld, per its Form 8-K filed April 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the following Class I director nominees was elected to serve on the Company's board of directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders, by the following vote:”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 97 asset managers below reported 19,395,385 for, 69 against, 3,992,650 withheld.

FORWITHHOLD
FOR: 19,395,385AGAINST: 69WITHHOLD: 3,992,650
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 0562,715Withhold
American Century00 0551,255Withhold
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 0408,888Withhold
Principal170,3830 0212,697Mixed
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS00 0321,135Withhold
State Street309,4990 0251For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 0272,141Withhold
Jackson National100,4250 0148,879Mixed
New York Life159,1710 089,332Mixed

Showing the 25 largest of 97 asset managers. All 97 are in the interactive database (link above).

Elect Director: William Hoffman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD
FOR: 33,808,366WITHHELD: 12,904,066
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Hoffman

INARI MEDICAL INC.’s own tally for this item (“Elect Director: William Hoffman”): 33,808,366 for, 12,904,066 withheld, per its Form 8-K filed April 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the following Class I director nominees was elected to serve on the Company's board of directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders, by the following vote:”
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 97 asset managers below reported 17,314,660 for, 69 against, 6,073,375 withheld.

FORWITHHOLD
FOR: 17,314,660AGAINST: 69WITHHOLD: 6,073,375
Largest asset managers voting on “To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and unt” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,176,7760 030,970For
AllianceBernstein00 0749,586Withhold
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds00 0562,715Withhold
American Century00 0551,255Withhold
AB DISCOVERY GROWTH FUND, INC.00 0479,248Withhold
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS00 0408,888Withhold
Principal5760 0382,504Withhold
Northwestern Mutual381,4050 00For
Equitable103,0200 0278,228Mixed
MFS00 0321,135Withhold
State Street1180 0309,632Withhold
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price00 0272,141Withhold
Jackson National100,4250 0148,879Mixed
New York Life159,1710 089,332Mixed

Showing the 25 largest of 97 asset managers. All 97 are in the interactive database (link above).

The compensation of the Company's named executive officers as disclosed in our proxy statement

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 44,404,487AGAINST: 2,164,720
Details: description as filed, official tally, votes by 308 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

INARI MEDICAL INC.’s own tally for this item (“3. The compensation of the Company's named executive officers as disclosed in our proxy statement”): 44,404,487 for, 2,164,720 against — passed, per its Form 8-K filed April 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in our proxy statement.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 96 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds562,7150 00For
American Century551,2550 00For
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS408,8880 00For
Principal383,0800 00For
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS321,1350 00For
State Street309,7500 00For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price272,1410 00For
Jackson National147,447101,857 00Mixed
New York Life248,5030 00For

Fund voting reports, all 96 managers: 23,175,569 for, 177,080 against, 35,386 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 242 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Wellington3,899,9610 00For
HCC Manager LLC2,591,6650 00For
AllianceBernstein2,024,3140 00For
BlackRock1,876,819369 00For
State Street1,571,7880 00For
BROWN ADVISORY INC1,559,1850 00For
GEODE CAPITAL MANAGEMENT, LLC1,168,4020 00For
UBS01,048,067 00Against
Franklin Templeton840,4770 00For
JPMorgan822,1050 00For
FIDUCIARY TRUST CO INTERNATIONAL753,1580 00For
Voya734,3400 00For
Nuveen605,3200 00For
American Century568,8160 00For
BAMCO INC /NY/566,5030 00For
BOSTON MANAGEMENT & RESEARCH511,1160 00For
Fiera Capital Corp507,1310 00For
FRANKLIN ADVISERS INC495,0090 00For
Bridgewater463,4400 00For
FRED ALGER MANAGEMENT, LLC461,8360 00For
Charles Schwab459,6270 00For
Slate Path Capital LP374,6060 00For
Allspring357,3860 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/354,4110 00For
T. Rowe Price344,3240 00For

Institutional-manager reports, all 242 managers: 28,786,845 for, 2,138,726 against. Showing the 25 largest; every one is in the interactive database (link above).

The selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 53,055,768AGAINST: 38,761
Details: description as filed, official tally, votes by 97 asset managers

Description as filed by funds: To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Company's fiscal year ending December 31, 2024.

INARI MEDICAL INC.’s own tally for this item (“2. The selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 53,055,768 for, 38,761 against — passed, per its Form 8-K filed April 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the selection of BDO USA, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 97 asset managers below reported 23,352,567 for, 151 against, 35,386 abstained.

FOR
FOR: 23,352,567AGAINST: 151ABSTAIN: 35,386
Largest asset managers voting on “To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Compan” at INARI MEDICAL INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,891,0030 00For
BlackRock3,161,1150 00For
Hartford2,391,6770 00For
Fidelity1,207,7460 00For
AllianceBernstein749,5860 00For
JPMorgan670,3920 00For
Voya591,4070 00For
MUTUAL FUND SERIES TRUST575,9140 00For
TIAA573,7670 00For
Brown Advisory Funds562,7150 00For
American Century551,2550 00For
AB DISCOVERY GROWTH FUND, INC.479,2480 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)466,0780 00For
FRANKLIN STRATEGIC SERIES452,1000 00For
Charles Schwab415,4610 00For
ALGER FUNDS408,8880 00For
Principal383,0800 00For
Northwestern Mutual381,4050 00For
Equitable381,2480 00For
MFS321,1350 00For
State Street309,7500 00For
Brown Capital Management Mutual Funds273,9630 00For
T. Rowe Price272,1410 00For
Jackson National249,3040 00For
New York Life248,5030 00For

Showing the 25 largest of 97 asset managers. All 97 are in the interactive database (link above).

Largest INARI MEDICAL INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 58,001,145 shares outstanding at the time of that meeting.

Fund voting reports: top INARI MEDICAL INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 8.43%
2BlackRock 5.45%
3Hartford 4.12%
4Fidelity 2.08%
5AllianceBernstein 1.29%
6JPMorgan 1.16%
7Voya 1.02%
8MUTUAL FUND SERIES TRUST 0.99%
9TIAA 0.99%
10Brown Advisory Funds 0.97%
Institutional-manager reports: top INARI MEDICAL INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Wellington 6.72%
2HCC Manager LLC 4.47%
3AllianceBernstein 3.49%
4BlackRock 3.24%
5State Street 2.71%
6BROWN ADVISORY INC 2.69%
7GEODE CAPITAL MANAGEMENT, LLC 2.01%
8UBS 1.81%
9Franklin Templeton 1.45%
10JPMorgan 1.42%

Reported INARI MEDICAL INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

INARI MEDICAL INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock, Inc.6,696,598 11.55%Proxy statement (DEF 14A), table as of February 28, 2024
The Vanguard Group5,038,292 8.69%Schedule 13G, filed February 13, 2024
Donald Milder3,086,714 5.32%Proxy statement (DEF 14A), table as of February 28, 2024
Franklin Templeton2,573,248 4.44%Form 13F, quarter ended March 31, 2024
State Street2,062,218 3.56%Form 13F, quarter ended March 31, 2024
Norges Bank1,311,905 2.26%Form 13F, quarter ended March 31, 2024
Wellington Management1,248,629 2.15%Form 13F, quarter ended March 31, 2024
Geode Capital1,183,294 2.04%Form 13F, quarter ended March 31, 2024
William Hoffman1,017,752 1.75%Proxy statement (DEF 14A), table as of February 28, 2024
Dimensional Fund Advisors712,025 1.23%Form 13F, quarter ended March 31, 2024

Percentages above are of 58,001,145 shares outstanding, as reported by INARI MEDICAL INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At INARI MEDICAL INC.'s shareholder meeting held April 24, 2024, in the 2023-2024 proxy season, 310 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 2,562 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — INARI MEDICAL INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: INARI MEDICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 25, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INARI MEDICAL INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

INARI MEDICAL INC. proxy season coverage: 2023-2024 (this page).

Cite this page

Proxy Votes Now, “INARI MEDICAL INC. 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/inari-medical-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.